ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Thermo Fisher Scientific Inc.

      Thermo Fisher Scientific Inc.

      TMO

      Market Cap$186.06B
      Close$

      Compare to Similar Companies

      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      Thermo Fisher Scientific Inc.Thermo Fisher Scientific Inc.28.30.33%13%4.30.7

      Earnings Call Q2 2025

      July 23, 2025 - AI Summary

      Financial Performance: Thermo Fisher reported Q2 2025 revenue of $10.85 billion, up 3% year-over-year, with adjusted operating income of $2.38 billion, reflecting 1% growth. Adjusted EPS was $5.36, exceeding guidance due to strong operational execution and better-than-expected tariff impacts.
      Guidance Update: The company has raised its full-year 2025 revenue guidance to a range of $43.6 billion to $44.2 billion, with adjusted EPS increased to $22.22 to $22.84. The outlook reflects enhanced operational management, incorporating approximately $300 million in additional cost reductions.
      Growth Segments: Key growth was seen in the pharma and biotech segments, reporting mid-single-digit growth. The bioproduction, Pharma Services, and research and safety market channels were strong performers. However, there was a decline in academic and government markets, reflecting hesitance in customer demand.

      Exclusive for Stockcircle Pro members

      Sign upSign Up
      $460.00

      Target Price by Analysts

      5.1% downsideThermo Fisher Scientific Target Price DetailsTarget Price
      $787.37

      Current Fair Value

      62.5% upside

      Undervalued by 62.5% based on the discounted cash flow analysis.

      Share Statistics

      Market cap$186.06 Billion
      Enterprise Value$216.71 Billion
      Dividend Yield$1.64 (0.33%)
      Earnings per Share$16.58
      Beta0.75
      Outstanding Shares378,000,000

      Return

      Return on Equity-
      Return on Assets-
      Return on Invested Capital-

      Valuation & Multiples

      P/E Ratio28.29
      PEG760.36
      Price to Sales4.25
      Price to Book Ratio3.64
      Enterprise Value to Revenue5.02
      Enterprise Value to EBIT45.58
      Enterprise Value to Net Income32
      Total Debt to Enterprise0.16
      Debt to Equity0.7

      Revenue Sources

      No data

      Insider Trades

      ESG Score

      No data

      About Thermo Fisher Scientific Inc.

      75,000 employees
      CEO: Marc Casper

      Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...

      HoMEÔçÒÒŮѸÀ×